Ad is loading...
MENU
YMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Y-mAbs Therapeutics (YMAB) Ownership - Who owns Y-mAbs Therapeutics?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
452.37M
P/E Ratio
N/A
Total Cash
68.12M
Projected Growth
N/A
Total Debt
1.08M
Revenue
84.55M
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash/Share
1.52
Total Debt/Equity
N/A
Revenue/Share
1.92 USD as % of share price
Fundamentals
YMAB
Capitalization
452M
P/E Ratio
N/A
Risk (Beta)
0.42
Dividend Yield
N/A
Total Cash
68.1M
Total Cash/Share
1.52
Total Debt
1.08M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.92%
Revenue
84.6M
ROE
N/A
Book Value
92.4M
P/B Ratio
5.11
Cash Flow
N/A
Earnings
-0.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
3.92
Current Revenue Per Employee
184610.00
Dividends Per Share - Security
N/A
EBITDA
-27.87M
Float
N/A
Float - Current
N/A
Gross Income Margin
87.82
Revenue To Assets
-19.11
Shares Held By Institutions
473M
Shares Outstanding - Current
44.8M
Total Liabilities
28.5M
Total Volume MTD
N/A
Value
N/A
Gain YTD
48.094
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel antibody therapeutics for oncology targets
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com